Internal Medicine, Pulmonary Disease · Alpharetta, GA
NPI
1598761223
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3400 Old Milton Pkwy # C, Ste 425
Alpharetta, GA, 30005
Phone (770) 343-8760
Groups this clinician bills Medicare through
Medicare paid, 2024
$81K
1,156 services
Medicare patients, 2024
627
Average age 75
Drug cost, 2024
$817K
2,037 prescriptions
Company payments, 2025
$2,845
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel F Callahan was code 99213 (office e&m - established), 392 times for 315 patients. In total Daniel F Callahan billed 1,156 services in 24 codes, and Medicare paid $81K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 392 | 315 | $64.97 | $25K |
| 99214 Office E&M - Established | Office | 146 | 113 | $95.29 | $14K |
| 95806 Sleep Study | Office | 120 | 120 | $31.64 | $3,796 |
| 99233 Hospital E&M - Subsequent | Facility | 96 | 53 | $92.25 | $8,856 |
| 99232 Hospital E&M - Subsequent | Facility | 62 | 45 | $61.34 | $3,803 |
| 99203 Office E&M - New | Office | 60 | 60 | $82.30 | $4,938 |
| 99204 Office E&M - New | Office | 39 | 39 | $112.33 | $4,381 |
| 95811 Sleep Study | Office | 39 | 36 | $84.88 | $3,310 |
| 95810 Sleep Study | Office | 37 | 37 | $90.47 | $3,347 |
| 94729 Pulmonary Function Testing | Office | 35 | 35 | $42.93 | $1,503 |
| 94375 Pulmonary Function Testing | Office | 26 | 26 | $29.31 | $762 |
| 99223 Hospital E&M - Initial | Facility | 24 | 24 | $134.45 | $3,227 |
| 99212 Office E&M - Established | Office | 18 | 18 | $39.43 | $710 |
| 71046 X-ray - Chest | Office | 17 | 16 | $24.45 | $416 |
| 31624 Bronchoscopy | Facility | 14 | 13 | $102.66 | $1,437 |
By year: 2022 $93K for 1,378 services; 2023 $90K for 1,295 services; 2024 $81K for 1,156 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel F Callahan prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 173 prescriptions and refills. In total Daniel F Callahan wrote 2,037 Medicare prescriptions that cost $817K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 173 | 287 | 39 | $174K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 144 | 186 | 55 | $3,407 |
| Prednisone Generic | 130 | 152 | 63 | $452 |
| Montelukast Sodium Generic | 126 | 287 | 42 | $1,301 |
| Azithromycin Generic | 85 | 104 | 37 | $559 |
| Trazodone Hcl Generic | 67 | 101 | 24 | $268 |
| Breo Ellipta Fluticasone/Vilanterol | 58 | 82 | 11 | $32K |
| Temazepam Generic | 52 | 58 | 14 | $710 |
| Cefuroxime Cefuroxime Axetil | 52 | 52 | 35 | $627 |
| Zolpidem Tartrate Generic | 50 | 60 | 15 | $288 |
| Lorazepam Generic | 48 | 50 | Under 11 | $177 |
| Modafinil Generic | 47 | 59 | 13 | $2,180 |
| Symbicort Budesonide/Formoterol Fumarate | 45 | 61 | 12 | $13K |
| Eliquis Apixaban | 41 | 57 | Under 11 | $34K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 40 | 68 | Under 11 | $32K |
Brand drugs: 812 claims; generic drugs: 1,225 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel F Callahan $2,845 ($2,845 in general payments such as food, travel and fees) from 27 companies. The largest payer was GlaxoSmithKline, LLC. with $403.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 20 | $403 |
| Harmony Biosciences LLC HRMY | 11 | $355 |
| Jazz Pharmaceuticals Inc. JAZZ | 9 | $291 |
| Genzyme Corporation SNY | 5 | $184 |
| Avadel CNS Pharmaceuticals, LLC | 6 | $169 |
| Inspire Medical Systems, Inc. INSP | 7 | $150 |
| Verona Pharma, Inc. VRNA | 4 | $119 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $117 |
| Insmed, Inc. INSM | 5 | $110 |
| Grifols USA, LLC | 5 | $109 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.